Download PDF
Thromb Haemost 2004; 92(03): 486-494
DOI: 10.1055/s-0037-1613739
Theme Issue Article
Schattauer GmbH

Murine thrombosis models

Sharlene M. Day
1   Departments of Internal Medicine, University of Michigan Medical School, Ann Arbor, Michigan, USA
,
Jennifer L. Reeve
1   Departments of Internal Medicine, University of Michigan Medical School, Ann Arbor, Michigan, USA
,
Daniel D. Myers
2   Surgery, University of Michigan Medical School, Ann Arbor, Michigan, USA
,
William P. Fay
1   Departments of Internal Medicine, University of Michigan Medical School, Ann Arbor, Michigan, USA
› Author AffiliationsFinancial support: This work was supported by NIH grants HL65224 and HL57346 (WPF) and by NIH T32 Training Grant HL07853 (SMD).
Further Information

Publication History

Received 14 May 2004

Accepted after revision 28 June 2004

Publication Date:
15 December 2017 (online)

Also available at
    Permissions and Reprints

Summary

Due to exciting advances in molecular biology, the laboratory mouse has become an important and frequently used model for studying thrombosis. This article reviews several experimental approaches that have been used to study arterial, venous, and microvascular thrombosis in mice. The advantages and limitations of different models are examined. Related topics of mouse anesthesia, phlebotomy, and in vitro hemostasis testing are also reviewed.

Keywords

Mouse or murine - animal models - thrombosis - haemostasis
 

  • References

  • 1 Tsakiris DA, Scudder L, Hodivala-Dilke K. et al. Hemostasis in the mouse (mus musculus): a review. Thromb Haemost 1999; 81: 177-88.
    Thieme ConnectPubMedSearch in Google Scholar
  • 2 Hogan KA, Weiler H, Lord ST. Mouse models in coagulation. Thromb Haemost 2002; 87: 563-74.
    Thieme ConnectPubMedSearch in Google Scholar
  • 3 Kurz KD, Main BW, Sandusky GE. Rat model of arterial thrombosis induced by ferric chloride. Thromb Res 1990; 60: 269-80.
    CrossrefPubMedSearch in Google Scholar
  • 4 Farrehi PM, Ozaki CK, Carmeliet P. et al. Regulation of arterial thrombolysis by plasminogen activator inhibitor-1 in mice. Circulation 1998; 97: 1002-8.
    CrossrefPubMedSearch in Google Scholar
  • 5 Zhu Y, Carmeliet P, Fay WP. Plasminogen activator inhibitor-1 is a major determinant of arterial thrombolysis resistance. Circulation 1999; 99: 3050-5.
    CrossrefPubMedSearch in Google Scholar
  • 6 Denis C, Methia N, Frenette PS. et al. A mouse model of severe von Willebrand disease: defects in hemostasis and thrombosis. Proc Natl Acad Sci 1998; 95: 9524-9.
    CrossrefPubMedSearch in Google Scholar
  • 7 Matsuno H, Uematsu T, Nagashima S. et al. Photochemically induced thrombosis model in rat femoral artery and evaluation of effects of heparin and tissue-type plasminogen activator with use of this model. J Pharmacol Methods 1991; 25: 303-17.
    CrossrefPubMedSearch in Google Scholar
  • 8 Kikuchi S, Umemura K, Kondo K. et al. Photochemically induced endothelial injury in the mouse as a screening model for inhibitors of vascular intimal thickening. Arterioscler Thromb Vasc Biol 1998; 18: 1069-78.
    CrossrefPubMedSearch in Google Scholar
  • 9 Saniabadi AR, Umemura K, Matsumoto N. et al. Vessel wall injury and arterial thrombosis induced by a photochemical reaction. Thromb Haemost 1995; 73: 868-72.
    Thieme ConnectPubMedSearch in Google Scholar
  • 10 Eitzman DT, Westrick RJ, Xu Z. et al. Hyperlipidemia promotes thrombosis after injury to atherosclerotic vessels in apolipoprotein E-deficient mice. Arterioscler Thromb Vasc Biol 2000; 20: 1831-4.
    CrossrefPubMedSearch in Google Scholar
  • 11 Eitzman DT, Westrick RJ, Nabel EG. et al. Plasminogen activator inhibitor-1 and vitronectin promote vascular thrombosis in mice. Blood 2000; 95: 577-80.
    CrossrefPubMedSearch in Google Scholar
  • 12 Myers DD, Hawley AE, Farris DM. et al. Pselectin and leukocyte microparticles are associated with venous thrombogensis. J Vasc Surg 2003; 38: 1075-89.
    CrossrefPubMedSearch in Google Scholar
  • 13 Angelillo-Scherrer A, Garcia Pde Frutos, Aparicio C. et al. Deficiency or inhibition of Gas6 causes platelet dysfunction and protects mice against thrombosis. Nature Med 2001; 07: 215-21.
    CrossrefPubMedSearch in Google Scholar
  • 14 Pierangeli SS, Liu XW, Barker JH. et al. Induction of thrombosis in a mouse by IgG, IgM and IgA immunoglobulins from patients with the antiphospholipid syndrome. Thromb Haemost 1995; 74: 1361-7.
    Thieme ConnectPubMedSearch in Google Scholar
  • 15 Pierangeli SS, Barker JH, Stikovac D. et al. Effect of human IgG antiphospholipid antibodies on an in vivo thrombosis model in mice. Thromb Haemost 1994; 71: 670-4.
    Thieme ConnectPubMedSearch in Google Scholar
  • 16 Oury C, Kuijpers MJE, Toth-Zsamboki E. et al. Overexpression of the platelet P2X1 ion channel in transgenic mice generates a novel prothrombotic phenotype. Blood 2003; 101: 3969-76.
    CrossrefPubMedSearch in Google Scholar
  • 17 Andre P, Delaney SM, LaRocca T. et al. P2Y12 regulates platelet adhesion/activation, thrombus growth, and thrombus stability in injured arteries. J Clin Invest 2003; 112: 398406.
    PubMedSearch in Google Scholar
  • 18 Rosen ED, Raymond S, Zollman A. et al. Laser-induced noninvasive vascular injury models in mice generate platelet- and coagulation- dependent thrombi. American Journal of Pathology 2001; 158: 1613-22.
    CrossrefPubMedSearch in Google Scholar
  • 19 Falati S, Gross P, Merrill-Skoloff G. et al. Real-time in vivo imaging of platelets, tissue factor and fibrin during arterial thrombus formation in the mouse. Nature Med 2002; 08: 1175-80.
    CrossrefPubMedSearch in Google Scholar
  • 20 Carmeliet P, Stassen JM, Schoonjans L. et al. Plasminogen activator inhibitor-1 gene-deficient mice. II. Effects on hemostasis, thrombosis, and thrombolysis. J Clin Invest 1993; 92: 2756-60.
    CrossrefPubMedSearch in Google Scholar
  • 21 Bdeir K, Murciano J-C, Tomaszewski J. et al. Urokinase mediates fibrinolysis in the pulmonary microvasculature. Blood 2000; 96: 1820-6.
    PubMedSearch in Google Scholar
  • 22 Broze Jr GJ, Yin Z-F, Lasky N. A tail vein bleeding time model and delayed bleeding in hemophiliac mice. Thromb Haemost 2001; 85: 747-8.
    Thieme ConnectPubMedSearch in Google Scholar
  • 23 Ware J, Russell S, Ruggeri ZM. Generation and rescue of a murine model of platelet dysfunction: the Bernard-Soulier syndrome. Proc Natl Acad Sci 2000; 97: 2803-8.
    CrossrefPubMedSearch in Google Scholar
  • 24 Peng L, Mundada L, Stomel JM. et al. Induction of heme oxygenase-1 expression inhibits platelet-dependent thrombosis. Antiox Redox Signal. In press.
    PubMed
  • 25 Kahn M, Zheng Y-W, Huang W. et al. A dual thrombin receptor system for platelet activation. Nature 1998; 394: 690-4.
    CrossrefPubMedSearch in Google Scholar
  • 26 Cui J, Eitzman DT, Westrick RJ. et al. Spontaneous thrombosis in mice carrying the factor V leiden mutation. Blood 2000; 96: 4222-6.
    PubMedSearch in Google Scholar
  • 27 Eitzman DT, Westrick RJ, Bi X. et al. Lethal perinatal thrombosis in mice resulting from the interaction of tissue factor pathway inhibitor deficiency and factor V Leiden. Circulation 2002; 105: 2139-42.
    CrossrefPubMedSearch in Google Scholar
  • 28 Konstantinides S, Schafer K, Thinnes T. et al. Plasminogen activator inhibitor-1 and its cofactor vitronectin stabilize arterial thrombi after vascular injury in mice. Circulation 2001; 103: 576-83.
    CrossrefPubMedSearch in Google Scholar